Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
Cardinal Health (CAH) concluded the recent trading session at $96.01, signifying a -0.9% move from its prior day's close.
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.
Cardinal Health, Inc. (CAH) Leerink Partners Healthcare Crossroads Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Leerink Partners Healthcare Crossroads Conference May 29, 2024 10:00 AM ET Company Participants Matt Sims - Head, IR Aaron Alt - CFO Conference Call Participants M...
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
For Cardinal Health, the Proof Will be in Its Performance
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim...
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH ) Q3 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lis...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.
Cardinal Health's stock falls on mixed quarterly results
Cardinal Health Inc.'s shares CAH, -0.84% fell 1.2% premarket on Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug dis...
Shhh! 3 Secret Retirement Stocks Flying Below Wall Street's Radar
Investing for retirement can be one of the most essential steps to securing a future of overall financial stability. Nowadays, many investors need to start preparing a nest egg at a young age despi...
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
US FDA sends warning to Cardinal Health for marketing unapproved devices
The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
A Repeat of 2022? 7 Defensive Stocks to Buy Before the Correction.
Are we headed for a repeat of 2022's brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags.
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
Related Companies